FDA adds new warning to weight loss drugs including Wegovy
Demonstrated herein, a tuned-down anti-Her2 biologic-CD3 TCE retained potent cytotoxicity against cells with high Her2 expression, comparable to its parental high-affinity counterpart, while showing reduced activity against cells with low Her2 levels, demonstrating improved selectivity and safety
Di Pietrantonj C, Rivetti A, Marchione P, Debalini MG, Demicheli V
The challenge with weight loss is that 30-40% of it can come from muscle or bone, which the body taps into, he noted
Some individuals taking Semaglutide or Tirzepatide may experience less weight loss than anticipated
So is considered well-tolerated and safe